Tilray Brands, Inc. Proceeds from Sale of Equity Method Investments
Tilray Brands, Inc. (TLRY) reported Proceeds from Sale of Equity Method Investments of $2.57 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfEquityMethodInvestments · last filed 2026-07-28
- Tilray Brands, Inc. proceeds from sale of equity method investments for the quarter ending 2021-05-31 was $1.00K.
- Tilray Brands, Inc. proceeds from sale of equity method investments for the quarter ending 2021-02-28 was $5.75M.
- Tilray Brands, Inc. proceeds from sale of equity method investments for the quarter ending 2020-11-30 was $0.00.
- Tilray Brands, Inc. proceeds from sale of equity method investments for the quarter ending 2020-08-31 was $2.68M.
- Tilray Brands, Inc. proceeds from sale of equity method investments for fiscal 2026 was $2.57M, a 691.98% increase from fiscal 2025.
- Tilray Brands, Inc. proceeds from sale of equity method investments for fiscal 2025 was $324.00K.
- Tilray Brands, Inc. proceeds from sale of equity method investments for fiscal 2024 was $0.00.
- Tilray Brands, Inc. proceeds from sale of equity method investments for fiscal 2023 was $0.00.
| Period end | Proceeds from Sale of Equity Method Investments 3 month | Proceeds from Sale of Equity Method Investments 6 month | Proceeds from Sale of Equity Method Investments 9 month | Proceeds from Sale of Equity Method Investments 12 month |
|---|---|---|---|---|
| 2026-05-31 | $2.57M 10-K · filed 2026-07-28 | |||
| 2025-05-31 | $324.00K 10-K · filed 2025-07-29 | |||
| 2024-05-31 | $0.00 10-K · filed 2024-07-30 | |||
| 2023-05-31 | $0.00 10-K · filed 2024-07-30 | |||
| 2022-05-31 | $0.00 10-K · filed 2024-07-30 | |||
| 2021-05-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | $5.75M derived: sum of 2 quarters · filed 2023-07-26 | $5.75M derived: sum of 3 quarters · filed 2023-07-26 | $8.43M 10-K · filed 2023-07-26 |
| 2021-02-28 | $5.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-06 | $5.75M derived: sum of 2 quarters · filed 2022-04-06 | $8.43M 10-Q · filed 2022-04-06 | |
| 2020-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-10 | $2.68M 10-Q · filed 2022-01-10 | ||
| 2020-08-31 | $2.68M 10-Q · filed 2021-10-07 | |||
| 2020-05-31 | $19.57M 10-K · filed 2022-07-28 | |||
| 2019-05-31 | $83.34M 10-K · filed 2021-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |